International Clinical Trial: A multicenter, randomized, double-blind, placebo- and active-controlled Phase II/III clinical trial evaluating the efficacy and safety of HL-1186 tablets for postoperative analgesia in orthopedics

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127101) titled 'A multicenter, randomized, double-blind, placebo- and active-controlled Phase II/III clinical trial evaluating the efficacy and safety of HL-1186 tablets for postoperative analgesia in orthopedics' on June 24.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Sichuan Provincial People's Hospital

Condition: Postoperative pain in orthopedics

Intervention: HL-1186 High-Dose Tablet Group:Oral HL-1186 low-dose tablet group:Oral Placebo group:Oral

Recruitment Status: Not Recruiting

Phase: 2-3

Date of First Enrollment: 2026-06-24

Target Sample Size: HL-1186 High-Dose Tablet Group:30;H...